Endoscopic appearance of GERD: putative role of cell proliferation
- PMID: 17606421
- DOI: 10.1016/j.dld.2007.05.002
Endoscopic appearance of GERD: putative role of cell proliferation
Abstract
Background: Erosive esophagitis is a frequent endoscopic feature in patients with gastro-oesophageal reflux disease. However, most of patients with heartburn/regurgitation have a non-erosive reflux disease. The reason for this heterogeneous impact of gastro-oesophageal reflux disease on oesophageal mucosa is unknown to date.
Aim: To evaluate the cell proliferation status of oesophageal epithelium in both healthy normal subjects and patients with gastro-oesophageal reflux disease with or without erosions.
Materials and methods: All the subjects underwent endoscopy and biopsies were taken at 5 cm from the squamo-columnar junction. Specimens were analysed both at histology and at transmission electron microscopy. Cell proliferation was evaluated by MIB1 immunostaining. Of the 85 subjects were studied, 10 were healthy controls with normal pH-testing and macroscopical, histological and ultrastructural patterns; 37 were patients with erosive esophagitis, and 38 patients with non-erosive reflux disease.
Results: At histology, of the 37 patients affected by erosive esophagitis, 30 had normal mucosa and 7 showed mild oesophagitis. One patient with non-erosive reflux disease showed signs of oesophagitis at histology. At TEM, all patients with gastro-oesophageal reflux disease had ultrastructural patterns of damage i.e. dilations of intercellular spaces (DIS), and all controls had a normal ultrastructural pattern. The mean (+/-SD) MIB1-LI values of normal subjects and non-erosive reflux disease and erosive oesophagitis patients were 62.2% (+/-9.1), 29.7% (+/-7.2) and 16.2% (+/-5.2), respectively; there were significant differences among the three groups (p<0.001).
Conclusions: Oesophageal mucosa of patients with reflux symptoms presents a decrease in MIB1 immunostaining of 50% and 25% in non-erosive reflux disease and erosive esophagitis patients with respect to normal subjects.
Similar articles
-
The extent of oesophageal acid exposure overlap among the different gastro-oesophageal reflux disease groups.Aliment Pharmacol Ther. 2006 Jan 15;23(2):321-9. doi: 10.1111/j.1365-2036.2006.02747.x. Aliment Pharmacol Ther. 2006. PMID: 16393313
-
Dilated intercellular spaces as a marker of oesophageal damage: comparative results in gastro-oesophageal reflux disease with or without bile reflux.Aliment Pharmacol Ther. 2003 Sep 1;18(5):525-32. doi: 10.1046/j.1365-2036.2003.01713.x. Aliment Pharmacol Ther. 2003. PMID: 12950425 Clinical Trial.
-
Gastro-oesophageal reflux disease is associated with up-regulation of desmosomal components in oesophageal mucosa.Histopathology. 2012 Feb;60(3):405-15. doi: 10.1111/j.1365-2559.2011.04123.x. Histopathology. 2012. PMID: 22276604
-
Review article: physiologic and clinical effects of proton pump inhibitors on non-acidic and acidic gastro-oesophageal reflux.Aliment Pharmacol Ther. 2006 Mar;23 Suppl 1:25-32. doi: 10.1111/j.1365-2036.2006.02802.x. Aliment Pharmacol Ther. 2006. PMID: 16483267 Review.
-
Current understanding of the mechanisms of gastro-oesophageal reflux disease.Drugs. 2006;66 Suppl 1:1-5; discussion 29-33. doi: 10.2165/00003495-200666001-00002. Drugs. 2006. PMID: 16869342 Review.
Cited by
-
Esophageal cell proliferation in gastroesophageal reflux disease: clinical-morphological data before and after pantoprazole.World J Gastroenterol. 2009 Feb 28;15(8):936-41. doi: 10.3748/wjg.15.936. World J Gastroenterol. 2009. PMID: 19248192 Free PMC article.
-
Cell proliferation of esophageal squamous epithelium in erosive and non-erosive reflux disease.World J Gastroenterol. 2011 Oct 28;17(40):4496-502. doi: 10.3748/wjg.v17.i40.4496. World J Gastroenterol. 2011. PMID: 22110280 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical